Wolfe Research initiated coverage of Guardant Health with a Peer Perform rating.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GH:
- Guardant Health, Cancer Research Horizons collaborate to advance cancer research
- Guardant Health to appeal intellectual property federal district court verdict
- Guardant Health upgraded to Outperform from Market Perform at Raymond James
- Guardant launches Shield blood-based screening test for CRC in South Korea
- Guardant Health price target lowered to $64 from $74 at Craig-Hallum